Cancer Insurance Denied in Hong Kong: Appeal Guide

A cancer diagnosis is devastating. A subsequent insurance denial adds financial crisis to medical hardship. In Hong Kong, cancer claims involve multiple types of insurance — hospital and surgical indemnity (including VHIS), critical illness (CI) plans, and cancer-specific riders. Understanding which policy applies and why the denial occurred is the first step to a successful appeal.

Types of Cancer Insurance in Hong Kong

Hospital and surgical indemnity plans (including VHIS). These plans cover in-hospital treatment, surgery, and associated specialist fees. They do not pay a lump sum — they reimburse actual expenses incurred during covered treatment. VHIS-certified plans must cover hospitalization for cancer treatment within their minimum package benefits.

Critical illness (CI) plans. CI policies pay a lump sum upon diagnosis of a specified critical illness, which typically includes cancer. The lump sum is typically a multiple of the sum insured (e.g., HK$500,000 to several million). The trigger is the diagnosis, not hospitalization.

Cancer-specific riders. Some policies include riders that pay additional benefits specifically for cancer — additional daily benefits during treatment, chemotherapy and radiotherapy benefits, or reconstruction surgery costs.

Life insurance with terminal illness benefits. Many life policies allow early payout if the insured is diagnosed as terminally ill with a prognosis of 12 months or less.

Common Denial Reasons for Cancer Claims

For Critical Illness Plans

Cancer definition disputes. CI policy definitions of cancer typically require a specific histological confirmation of malignancy. Denials arise when:

• The cancer is classified as early-stage or in situ, which some older CI policies exclude
• The tumor is borderline malignant, falling outside the policy's cancer definition
• Skin cancers other than malignant melanoma are excluded (a common exclusion)
• A waiting period (typically 90 days) was not met

If your insurer argues your cancer does not meet the CI definition, get your oncologist's written opinion and the pathology report. Many policies have been updated to cover earlier-stage cancers, but older policies may still apply narrow definitions.

Waiting period not met. Most CI policies impose a 90-day waiting period from policy start. Cancer diagnosed within 90 days of taking out the policy will be denied.

Non-disclosure. If the insurer believes you had cancer or suspicious symptoms before the policy started and did not disclose them, they may deny the claim on non-disclosure grounds.

For Hospital and Surgical Plans (Including VHIS)

Treatment classified as experimental. Newer cancer treatments — immunotherapy, targeted therapy, CAR-T cell therapy — may be denied as experimental or non-standard. This is a major current issue in Hong Kong cancer claims.

Day procedure versus in-patient. Many chemotherapy and targeted therapy regimens are administered on a day-patient basis. Some plans only cover in-patient (overnight) admissions. Verify how your plan defines in-patient treatment.

Drug sub-limits. Hospital plans may cover surgical fees and room charges but apply tight sub-limits on drugs and medications. Cancer drugs can be extraordinarily expensive; the drug sub-limit may be exhausted quickly.

Cosmetic classification of reconstruction. Post-mastectomy breast reconstruction is medically necessary, not cosmetic. If your insurer has denied reconstruction costs as cosmetic, challenge this directly with your surgeon's letter.

How to Appeal a Cancer Insurance Denial

Step 1: Identify Which Policy and Which Coverage Clause Is in Dispute

You may hold multiple relevant policies. List each one, identify what benefit you are claiming, and focus your appeal on the specific clause the insurer cited. Mixing up CI appeal arguments with hospital plan appeal arguments weakens both.

Step 2: Build Your Medical Evidence

• Pathology report confirming diagnosis, stage, and histological type
• Oncologist's letter on medical necessity and treatment rationale
• Clinical guidelines from the Hong Kong Medical Association or international oncology bodies (NCCN, ESMO) supporting your treatment protocol
• For CI plans: confirmation that your diagnosis meets the medical definition of cancer under your policy

Step 3: Internal Complaint

Submit a formal complaint to the insurer, citing the specific policy clause, your diagnosis, and why the clause should apply. For CI definition disputes, attach the pathology report and your oncologist's explanation of the diagnosis.

Step 4: ICCB

If the insurer upholds the denial, file with the ICCB at iccb.org.hk. Cancer-related disputes — particularly CI definition disputes — are regularly adjudicated by the ICCB. File within 6 months of the final decision.

Step 5: Independent Medical Expert

For CI definition disputes, consider engaging an independent oncologist to provide a report supporting your case. The ICCB gives weight to independent expert opinions.

Step 6: Insurance Authority

For regulatory conduct issues, file with the IA at ia.org.hk. The IA monitors market conduct and takes action when insurers systematically misapply policy terms.

Key Advice

Do not accept the insurer's characterization of your medical condition without independent medical confirmation. In cancer claims, the difference between in situ and invasive, or between malignant melanoma and other skin cancer, can determine whether a HK$1 million CI claim is paid. Your oncologist knows your case — make sure the insurer sees their full opinion.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word. Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal